Comparison of the Intestinal Drug Permeation and Accumulation Between Normal Human Intestinal Tissues and Human Intestinal Tissues With Ulcerative Colitis

被引:8
|
作者
Nakai, Daisuke [1 ]
Miyake, Masateru [1 ,2 ]
Hashimoto, Ayako [2 ]
机构
[1] Uppsala Univ, Dept Pharm, Husargatan 3, S-75123 Uppsala, Sweden
[2] Otsuka Pharmaceut Co Ltd, Qual Assurance Sect, Qual Assurance Dept, Headquarters Prod Safety & Qual Assurance, Matsudani Itano, Tokushima 7790195, Japan
关键词
human absorption; ulcerative colitis (UC); human tissues; transport index (TI); autopsy grade; USSING CHAMBER SYSTEM; PERMEABILITY; ABSORPTION; PREDICTION;
D O I
10.1016/j.xphs.2019.12.015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to examine drug absorption profile utilizing human intestinal tissues from ulcerative colitis (UC) patients and to compare with normal tissues from intestinal cancer patients. Human intestinal tissues from UC and cancer patients mounted in a mini-Ussing chamber were used to evaluate the permeation of drugs, including FD-4, a very low permeable marker, rebamipide, a low permeable marker, and metoprolol, a high permeable marker. The transport index, an index of sum of permeated and tissue-accumulated molecules, of the model drugs was in accordance with their absorption rank order, and was almost kept constant irrespective of autopsy grade based on tissue fibrosis. On the other hand, UC tissues of grade 2 showed the decreased X-corr, an index of permeated amount of molecules and increased T-corr, an index of tissue-accumulated molecules for every tested compound. Our finding of the transport characteristics in intestinal tissues of severe UC patients in mini-Ussing chamber system demonstrated that autopsy grade of UC patients did not drastically change membrane permeability of the tested compounds. Furthermore, it was suggested that morphological changes of intestinal tissues caused by fibrosis led to limited permeation and subsequently increased accumulation with little change of total absorption. (C) 2019 American Pharmacists Association (R) . Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1623 / 1626
页数:4
相关论文
共 50 条
  • [31] EPICERTIN ENHANCES INTESTINAL WOUND HEALING IN A MOUSE COLITIS MODEL AND HUMAN ULCERATIVE COLITIS COLON EXPLANTS
    Royal, Joshua M.
    Oh, Youngjun
    Galandiuk, Susan
    Matoba, Nobuyuki
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S11 - S11
  • [32] Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues
    Weiss, AA
    Babyatsky, MW
    Ogata, S
    Chen, A
    Itzkowitz, SH
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1996, 44 (10) : 1161 - 1166
  • [33] Distinct accumulation of nanoplastics in human intestinal organoids
    Hou, Zongkun
    Meng, Run
    Chen, Ganghua
    Lai, Tangmin
    Qing, Rui
    Hao, Shilei
    Deng, Jia
    Wang, Bochu
    SCIENCE OF THE TOTAL ENVIRONMENT, 2022, 838
  • [34] Quantitation of small intestinal permeability during normal human drug absorption
    David G Levitt
    BMC Pharmacology and Toxicology, 14
  • [35] Quantitation of small intestinal permeability during normal human drug absorption
    Levitt, David G.
    BMC PHARMACOLOGY & TOXICOLOGY, 2013, 14
  • [36] Comparison of Microplastics between Lung Tissues and Intestinal Contents in Finless Porpoises (Neophocaena asiaeorientalis)
    Park, Byeongyong
    Lee, Youngran
    Kim, Taewon
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2025,
  • [37] ACCUMULATION OF DONOR-SPECIFIC CYTOTOXIC T-CELLS IN INTESTINAL LYMPHOID-TISSUES FOLLOWING INTESTINAL TRANSPLANTATION
    SIRINEK, LP
    ODORISIO, MS
    DUNAWAY, DJ
    JOURNAL OF CLINICAL IMMUNOLOGY, 1995, 15 (05) : 258 - 265
  • [38] Organotypic in vitro human small intestinal tissue models to assess drug toxicity and permeation
    Ayehunie, S.
    Stevens, Z.
    Landry, T.
    Tami, M.
    Klausner, M.
    Hayden, P.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S193 - S194
  • [39] Human small intestinal organotypic culture model for drug permeation, inflammation, and toxicity assays
    Jan Markus
    Tim Landry
    Zachary Stevens
    Hailey Scott
    Pierre Llanos
    Michelle Debatis
    Alexander Armento
    Mitchell Klausner
    Seyoum Ayehunie
    In Vitro Cellular & Developmental Biology - Animal, 2021, 57 : 160 - 173
  • [40] Human small intestinal organotypic culture model for drug permeation, inflammation, and toxicity assays
    Markus, Jan
    Landry, Tim
    Stevens, Zachary
    Scott, Hailey
    Llanos, Pierre
    Debatis, Michelle
    Armento, Alexander
    Klausner, Mitchell
    Ayehunie, Seyoum
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2021, 57 (02) : 160 - 173